Proteinuria in diabetes: An endocrine disease?

Current Diabetes Reviews

Volumn 7, Issue 1, 2011, Pages 1-2

  Lenz, Oliver ^a   Fornoni, Alessia ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ALDOSTERONE; ANGIOTENSIN II; BETA CATENIN; ESTROGEN; GROWTH HORMONE; HEMOGLOBIN A1C; HORMONE; INSULIN; LEVOTHYROXINE; MINERALOCORTICOID RECEPTOR; PRORENIN; RAC1 PROTEIN; SEX HORMONE; SOMATOMEDIN C; VITAMIN D; WNT PROTEIN;

ALBUMINURIA; CALCIUM METABOLISM; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIAPHRAGM; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; ENDOCRINE DISEASE; GENE EXPRESSION; HUMAN; HYPERINSULINEMIA; HYPOTHYROIDISM; INSULIN RESISTANCE; KIDNEY DISEASE; KIDNEY FAILURE; NONHUMAN; PATHOGENESIS; PHOSPHATE METABOLISM; PODOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 79952751583     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339911794273937     Document Type: Editorial

References (16)

1. USRDS. USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2007.
2. Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646-661.
3. Somlo S, Mundel P. Getting a foothold in nephrotic syndrome. Nat Genet 2000; 24: 333-335.
4. Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006; 354: 1387-1401.
5. Faul C, Asanuma K, Yanagida-Asanuma E, et al. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007; 17: 428-437.
6. Benzing T. Signaling at the slit diaphragm. J Am Soc Nephrol 2004; 15: 1382-1391.
7. Jauregui A, Mintz DH, Mundel P, et al. Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria. Curr Opin Nephrol Hypertens 2009; 18: 539-545.
8. Prabhu A, Xu Q, Manigrasso MB, et al. Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes. Steroids 2010; 75(11): 779-787.
9. Gutwein P, Abdel-Bakky MS, Schramme A, et al. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am J Pathol 2009; 174: 2061-2072.
10. Mayrhofer C, Krieger S, Huttary N, et al. Alterations in fatty acid utilization and an impaired antioxidant defense mechanism are early events in podocyte injury: a proteomic analysis. Am J Pathol 2009; 174: 1191-1202.
11. Sieber J, Lindenmeyer MT, Kampe K, et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am J Physiol Renal Physiol 299: F821-829.
12. Yamada S, Bandai S, Masutani K, et al. Focal segmental glomerulosclerosis in a patient with isolated ACTH deficiency and reversible hypothyroidism. Clin Exp Nephrol 2010; 14(2): 168-172.
13. Rauen T, Michaelis A, Floege J, et al. Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24. Clin Nephrol 2009; 71: 637-642.
14. Havt A, Schally AV, Halmos G, et al. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci U S A 2005; 102: 17424-17429.
15. Chen HS, Wu TE, Jap TS, et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabet Med 2007; 24: 1336-1344.
16. Miura M, Nomoto Y, Sakai H. Prevention of progressive renal failure by levothyroxine sodium in a diabetic patient with renal insufficiency and hypothyroidism. Intern Med 1992; 31: 251-255.